Literature DB >> 23494825

Opportunity and innovation in studying pre-symptomatic amyotrophic lateral sclerosis.

Michael Benatar, Joanne Wuu, John Ravits.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23494825     DOI： 10.1002/mus.23782

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  4 in total

1.  Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.

Authors:  Ching-Hua Lu; Corrie Macdonald-Wallis; Elizabeth Gray; Neil Pearce; Axel Petzold; Niklas Norgren; Gavin Giovannoni; Pietro Fratta; Katie Sidle; Mark Fish; Richard Orrell; Robin Howard; Kevin Talbot; Linda Greensmith; Jens Kuhle; Martin R Turner; Andrea Malaspina
Journal:  Neurology       Date:  2015-05-01       Impact factor: 9.910

2.  Altered cortical beta-band oscillations reflect motor system degeneration in amyotrophic lateral sclerosis.

Authors:  Malcolm Proudfoot; Gustavo Rohenkohl; Andrew Quinn; Giles L Colclough; Joanne Wuu; Kevin Talbot; Mark W Woolrich; Michael Benatar; Anna C Nobre; Martin R Turner
Journal:  Hum Brain Mapp       Date:  2016-09-13       Impact factor: 5.038

Review 3.  Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis.

Authors:  Malcolm Proudfoot; Peter Bede; Martin R Turner
Journal:  Front Neurol       Date:  2019-01-08       Impact factor: 4.003

4.  T₂-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS.

Authors:  Matthew C Evans; Sébastien Serres; Alexandre A Khrapitchev; Helen B Stolp; Daniel C Anthony; Kevin Talbot; Martin R Turner; Nicola R Sibson
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-05       Impact factor: 6.200
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.